Metallic taste as a side effect of topical fluorouracil use

Journal of Drugs in Dermatology

Volumn 10, Issue 10, 2011, Pages 1201-1203

  Han, Sandra Y ^a   Youker, Summer ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ADULT; ARTICLE; CASE REPORT; CRYOTHERAPY; DRUG SAFETY; DYSGEUSIA; FEMALE; FOLLOW UP; HUMAN; SKIN BIOPSY; SKIN CARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, CUTANEOUS; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; DYSGEUSIA; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; SKIN NEOPLASMS;

EID: 80054748438     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Eaglstein WH, Weinstein GD, Frost P. Fluorouracil mechanism of action in human skin and actinic keratosis. I. Effect on DNA synthesis in vivo. Arch Dermatol. 1970;101:132-139.
2. Diasio RB, Harris BE. Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet. 1989;16:215-237. (Pubitemid 19114713)
3. Fallon G, Schulz EJ. Skin changes in patients treated with 5-fluorouracil. Brit J Dermatol. 1962;74:229-236.
4. Klein E, Helm F, Milgrom H, et al. Tumors of the skin. II. Keratoacanthoma: Local effect of 5-fluorouracil. Skin. 1962;1:153-156.
5. Sturm HM. Bowen's disease and 5-fluorouracil. J Am Acad Dermatol. 1979;1:513-522.
6. Bargman H, Hochman J. Topical treatment of Bowen's disease with 5-fluorouracil. J Cutan Med Surg. 2003;7:101-105. (Pubitemid 36506157)
7. Jansen GT. Topical therapy with 5-fluorouracil. J Surg Oncol. 1971;3:317-323.
8. Goette DK, Odom RB, Owens R. Allergic contact dermatitis from topical fluorouracil. Arch Dermatol. 1977;113;196-198. (Pubitemid 8033160)
9. Burnett JW. Two unusual complications of topical fluorouracil therapy. Arch Dermatol. 1975;111:398.
10. Burnett JW. Further observations on two unusual complications of topical fluorouracil therapy. Arch Dermatol. 1982;118:74. (Pubitemid 12162253)
11. Dillaha CJ, Jansen GT, Honeycutt WM, et al. Selective cytotoxic effect of topical 5-fluorouracil. Arch Dermatol. 1963;88:247-256.
12. Goldman, L. The response of skin cancer to topical therapy with 5-fluorouracil. Canc Chemother Rep. 1968;28:49-52.
13. Fluorouracil cream [package insert]. Hawthorne, NY: Taro Pharmaceuticals USA Inc.; 2010.
14. Tirgan MA. Efficacy of dexamethasone in prevention of chemotherapy induced disturbance of taste. J Clin Oncol. 2005;23(suppl 16):8136.
15. Guidice M. Taste disturbances linked to drug use. Can Pharm J. 2006;139:70-73.
16. Wickham RS, Rehwaldt M, Kefer C, et al. Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum. 1999;26:697-706.
17. Bernhardson BM, Tishelman C, Rutqvist LE. Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer. 2008;16:275-283. (Pubitemid 351422804)
18. Hong JH, Omur-Ozbek P, Stanek B, et al. Taste and odor abnormalities in cancer patients. J Support Oncol. 2009;7:58-65.
19. Nahikian-Nelms ML. General feeding problems. In: Bloch AS, ed. Nutrition Management of the Cancer Patient. Sudbury, Mass: Jones and Bartlett Publishers; 1990:47.
20. Dillaha CJ, Jansen GT, Honeycutt WM, et al. Further studies with topical 5-fluorouracil. Arch Dermatol. 1965;92:410-418.
21. Levy S, Furst K, Chern W. A pharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis. Clin Ther. 2001;23:908-919.
22. Erlanger M, Martz G, Ott F, et al. Cutaneous absorption and urinary excretion of 6-14C-5-fluorouracil ointment applicated in an ointment to healthy and diseased human skin. Dermatologica. 1970;140(suppl 1):7-14.
23. Johnson MR, Hageboutros A, Wang K, et al. Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil. Clin Cancer Res. 1999;5:2006-2011. (Pubitemid 29399251)